<DOC>
	<DOCNO>NCT00211653</DOCNO>
	<brief_summary>The purpose study determine Acetylcysteine effective prevent renal failure associate cardiac surgery</brief_summary>
	<brief_title>Acetylcysteine Prevention Renal Failure After Bypass Surgery</brief_title>
	<detailed_description>Postoperative renal dysfunction predictor significant morbidity mortality among patient undergo cardiac surgery . The mortality associate coronary artery by-pass surgery increase 2 % almost 19 % patient renal failure approach 60 % patient require hemodialysis . Patients preoperative renal dysfunction refer coronary artery pas surgery extraordinarily high risk require postoperative dialysis . For example , among patient preoperative creatinine &gt; 2.5 mg/dL , almost 50 % require hemodialysis . Comparison : N-Acetylcysteine superior placebo prevent renal failure cardiac surgery</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Pts baseline chronic kidney disease ( eGFR &lt; 60 ml/min/1.73m2 ) undergo cardiac surgery Patients hemodialysis preoperatively IV contrast within 4 day prior surgery Urgent/emergent surgery History renal transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Kidney failure</keyword>
	<keyword>Thoracic surgery</keyword>
	<keyword>Acetylcysteine</keyword>
</DOC>